| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc. | President & CEO, Director | Common Stock | 390K | $31.4M | $80.34 | Nov 3, 2023 | Direct |
| Relay Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 102K | Jun 3, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
| SRPT | Sarepta Therapeutics, Inc. | Nov 3, 2023 | 4 | $2M | 4 | Nov 6, 2023 | President & CEO, Director |
| RLAY | Relay Therapeutics, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 1, 2023 | Director |
| RLAY | Relay Therapeutics, Inc. | May 27, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| SRPT | Sarepta Therapeutics, Inc. | Nov 17, 2021 | 1 | $2M | 4 | Nov 17, 2021 | President & CEO, Director |
| SRPT | Sarepta Therapeutics, Inc. | Jun 26, 2021 | 1 | -$1.43M | 4 | Jun 28, 2021 | President & CEO, Director |
| RLAY | Relay Therapeutics, Inc. | May 19, 2021 | 1 | $0 | 4 | May 21, 2021 | Director |